Condition
Recurrent Uti
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
80.0%
-6.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results80% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
Early P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Completed4
Terminated1
Trial Success Rate
80.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06149676Early Phase 1CompletedPrimary
A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections
NCT06332781Phase 4CompletedPrimary
Intravesical Gentamicin to Prevent Recurrent UTI
NCT04096820Phase 2TerminatedPrimary
Uromune in Treating Recurrent Urinary Tract Infections in Women
NCT03644966Not ApplicableCompleted
Probiotics and Multi-Drug Resistant Urinary Tract Infection
NCT03210038Not ApplicableCompleted
Cystoscopy in Females: Is There a Difference Between Rigid and Flex Cystoscopy, and Does it Require Local Anasthesia?
Showing all 5 trials